Risk stratification in hypertrophic cardiomyopathy: time for renewal?

Abstract excerpt

Systematic clinical assessment and careful monitoring of patients with hypertrophic cardiomyopathy (HCM) can be used to identify a cohort of patients that benefit from medical intervention and almost certainly improve long-term outcomes. One of the major limitations of the current approach is a lack of predictive power of individual risk factors, which means that many patients receive therapy. The aim of this...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Atrial Fibrillation
• Share to Cardiomyopathy, Hypertrophic, Familial